• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Lisa M. DiGianni, Ph.D.


  • Keating NL,Stoeckert KA,Regan MM,DiGianni L,Garber JE.Physicians' experiences with BRCA1/2 testing in community settings.J Clin Oncol. 2008 Dec 10;26(35):5789-96.
  • Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE.F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.JAMA. 2008 Mar 19;299(11):1315-9.
  • Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE.Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.J Clin Oncol. 2006 Feb 1;24(4):700-6.
  • Digianni LM, Rue M, Emmons K, Garber JE.Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):70-5.
  • Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S.Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.Gastroenterology. 2006 Jan;130(1):73-9.
  • Schneider KA, DiGianni LM, Patenaude AF, Klar N, Stopfer JE, Calzone KA, Li FP, Weber BL, Garber JE.Accuracy of cancer family histories: comparison of two breast cancer syndromes.Genet Test. 2004 Fall;8(3):222-8.
  • DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, Garber JE.Complementary medicine use among women enrolled in a genetic testing program.Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):321-6.
  • Li FP, DiGianni LM.Reducing the unequal burden of cancer.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):230s-231s.
  • DiGianni LM, Garber JE, Winer EP.Complementary and alternative medicine use among women with breast cancer.J Clin Oncol. 2002 Sep 15;20(18 Suppl):34S-8S.
  • Emmons KM, Sorensen G, Klar N, Digianni L, Barclay G, Schmidt K, Hammond SK.Healthy baby second-hand smoke study: project brief.Tob Control. 2000;9 Suppl 3:III58-60.
  • Dorval M, Patenaude AF, Schneider KA, Kieffer SA, DiGianni L, Kalkbrenner KJ, Bromberg JI, Basili LA, Calzone K, Stopfer J, Weber BL, Garber JE.Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.J Clin Oncol. 2000 May;18(10):2135-42.